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Abstract 
A synthesis of the naturally occurring xanthone toxyloxanthone B is described, in which the 
key step is the regioselective addition of a methyl salicylate to a substituted benzyne followed 
by cyclization of the intermediate aryl anion to form the xanthone, the regiochemistry of the 
aryne addition being confirmed by X-ray crystallography. Subsequent introduction of the 
pyran ring by [3,3]-rearrangement and deprotection completed the synthesis. 
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1. Introduction 
Xanthones are widely distributed in Nature, occurring in a wide range of organisms from 
bacteria to higher plants.1 Not only are xanthones highly colored (Greek xanthos = yellow), 
they are also endowed with significant biological activity. Plants and trees of the Garcinia 
genus are a particularly rich source of bioactive xanthones, and recently isolated examples 
possess activity against platelet aggregation,2 α-glucosidases,3 cancer,4 and MRSA.5,6 In 
higher plants, xanthones are of mixed polyketide and shikimic acid biosynthetic origin, with 
many examples also possessing isoprene-derived side chains.3-5 Indeed it was prenylated 
xanthones such as α-mangostin 1, rubraxanthone 2 and toxyloxanthone B 3a (Figure 1) that 
attracted our attention. α-Mangostin 1, from Garcinia mangostana, is a potent inhibitor of 
sphingomyelinase,7,8 whereas rubraxanthone 2, isolated from various members of the 
Garcinia genus,9,10 has a range of biological properties.11,12 The cytotoxic xanthone 
toxyloxanthone B 3a on the other hand is not Garcinia derived being originally isolated from 
Maclura pomifera and Toxylon pomiferum,13-16 and subsequently from the Hypericum genus, 
including H. perforatum (St John’s Wort).17,18 Surprisingly despite their relative structural 
simplicity α-mangostin 1 is the only one of the three compounds to be synthesized.8 We now 
report the synthesis of toxyloxanthone 3 that not only constitutes the first synthesis of the 
natural material, but also, as far as we are aware, illustrates the first use of the aryne-based 
methodology developed by Larock19,20 in the synthesis of bioactive natural products. 
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Figure 1. Some naturally occurring prenylated xanthones. 
 2. Results and discussion 
The toxyloxanthones were first isolated from Maclura pomifera,13 although the originally 
assigned structure of toxyloxanthone B was corrected some two years later. Specifically, the 
position of the two methyl groups at C-3 was confirmed by NMR spectroscopy,14 and 
subsequently confirmed by an unambiguous synthesis of the trimethyl ether 3b,15,16 although 
the natural product itself has not been synthesized. In common with many other route to 
xanthones, the synthesis of toxyloxanthone B trimethyl ether 3b was achieved in a classical 
sense by way of a suitably substituted benzophenone,16 but we were attracted by the more 
contemporary aryne-based method introduced by Larock.19,20 There has been a recent 
resurgence in interest in aryne chemistry, and their application in natural product synthesis is 
extremely topical.21-23 The Larock method involves the nucleophilic addition of the hydroxy 
group of a methyl salicylate to a benzyne followed by cyclization of the resuting aryl anion 
onto the methyl ester (Scheme 1). In the case of toxyloxanthone B 3a, the required coupling 
partners would be the methyl salicylate 4 and the ortho-trimethylsilyl triflate aryne precursor 
5, with benzyl protecting groups chosen for the three phenolic hydroxy groups, with the 
remaining phenol in 4 orthogonally protected as its MOM-ether. The substituted benzyne 
derived from precursor 5 is unsymmetrical and therefore could lead to two nucleophilic 
addition products. However, Stoltz and co-workers have previously shown that the aryne 
derived from 5 undergoes regioselective attack as indicated in Scheme 1,24 and therefore we 
were confident that the correct xanthone would result from our projected coupling reaction. 
 
OH
CO2Me
O
O OMe
O
O
OH
CO2MeMOMO
BnO
OBn
OBnTfO
Me3Si
OBn
OBnNuc
4 5  
Scheme 1. Larock benzyne-based route to xanthones, and the proposed precursors to 
toxyloxanthone B. 
 
The methyl salicylate 4 was obtained from methyl 2,4-hydroxybenzoate 6 by selective 
protection of the non-hydrogen bonded phenol to give salicylate 7. Subsequent Elbs persulfate 
oxidation25 gave the hydroquinone 8 albeit in poor yield, although the 64% recovery of 
starting material 7 rendered the process viable. Selective protection of the non-hydrogen 
bonded phenol as its MOM-ether gave the required methyl salicylate 4 (Scheme 2). The aryne 
precursor 5 was prepared from phloroglucinol as described by Stoltz and co-workers,24 setting 
the stage for the key step. Generation of the aryne from the triflate 5 with cesium fluoride in 
THF in the presence of the methyl salicylate 4 as described by Larock and co-workers gave 
the desired xanthone 9, but in 1:1 admixture with the ortho-aryloxy benzoate 10 (Scheme 2). 
Reasoning that the only source of protonation of the intermediate aryl anion was the salicylate 
4 itself, a change in conditions involving the addition of sodium hydride for prior 
deprotonation of the phenol resulted in an improved yield (40%) of the desired xanthone 9, 
although the benzoate 10 was still formed (30%). As expected, the nucleophilic addition to 
the unsymmetrical benzyne derived from triflate 5 was highly regioselective resulting in the 
formation of the 1,3,6-tribenzyloxyxanthone 9. The alternative regioisomer, the 2,4,6-
tribenzyloxyxanthone, that would result from attack on the other aryne carbon was not 
observed. In terms of obtaining quantities of xanthone 9, the formation of benzoate 10 was 
inconsequential since ester hydrolysis and cyclization onto the electron rich aromatic ring in 
the presence of trifluoroacetic acid anhydride provided further material. 
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Scheme 2. Reagents and conditions. a, BnBr, K2CO3, acetone, rt (82%); b, K2S2O8, NaOH, 
water, rt (15% + 64% recovered 7); c, MOMCl, i-Pr2NEt, CH2Cl2, rt (70%); d, NaH, CsF, 
THF, 65 °C (40% + 30% 10); e, LiOH, MeOH, aq THF, then TFAA, CH2Cl2, rt (99%); f, 
TFA, CH2Cl2, rt (94%); g, MgBr2, toluene, reflux (10%); h, HCCCMe2Cl, KI, K2CO3, 
acetone, reflux (75%); i, toluene, reflux (100%); j, BCl3 (1 M in hexane), 
pentamethylbenzene, CH2Cl2, -78 °C, then rt (64%).  
 
With the xanthone 9 available in quantity, the MOM-ether was cleaved under acidic 
conditions, and the resulting phenol 11 was further deprotected by selective removal of the 
benzyl group peri-to the carbonyl by treatment with magnesium bromide in boiling toluene. 
The structure of the resulting phenol 12 was confirmed by X-ray crystallography (Figure 2), 
providing unambiguous evidence for the regiochemistry of the aryne addition. Alkylation of 
phenol 11 with 3-chloro-3-methylbutyne gave the propargyl ether 13 in good yield. Claisen 
rearrangement under mild conditions26 resulted in formation of the fused pyran ring in good 
yield to give protected toxyloxanthone 14 (Scheme 2). The final step required the removal of 
three benzyl protecting groups, and although this could not be carried out under catalytic 
transfer hydrogenation with ammonium formate as hydrogen donor,27 treatment with boron 
trichloride in dichloromethane in the presence of pentamethylbenzene28 at -78 °C initially 
removed two of the benzyl groups. For full deprotection, the reaction mixture required 
warming to room temperature with extra boron trichloride, which pleasingly gave the 
xanthone 3a (toxyloxanthone) in 64% yield.  
 
Figure 2. X-Ray crystal structure of 3,6-dibenzyloxy-1,7-dihydroxy-9H-xanthen-9-one 12 
(with one molecule of chloroform) CCDC number 973933. 
 
The 1H spectroscopic properties of the synthetic material closely matched those described for 
the natural product,17,18 although the 13C NMR gave a systematic difference in the chemical 
shifts of 0.8-1.1 ppm. We assumed that this was due to incorrect calibration of the original 
spectrum, and indeed when we re-referenced the residual acetone peak, a near perfect match 
to the reported literature values was observed. Additionally, for further comparison, 
toxyloxanthone B 3a was converted into the known trimethyl ether 3b by reaction with 
dimethyl sulfate, the 1H NMR spectroscopic data of which were identical with those 
reported.16 The first synthesis of the naturally occurring xanthone toxyloxanthone B further 
demonstrates the use of arynes in synthesis, and in particular that the Larock xanthone 
methodology can be successfully applied in the synthesis of relatively complex natural 
products. 
 
3. Experimental section 
3.1 General information 
Commercially available reagents were used throughout without purification unless otherwise 
stated. All anhydrous solvents were used as supplied, except tetrahydrofuran and 
dichloromethane that were freshly distilled according to standard procedures. Reactions were 
routinely carried out under an argon atmosphere unless otherwise stated, and all glassware 
was flame-dried before use. Light petroleum refers to the fraction with bp 40-60 ºC. Ether 
refers to diethyl ether. 
Analytical thin layer chromatography was carried out on aluminum backed plates coated with 
silica gel, and visualized under UV light at 254 and/or 360 nm and/or by chemical staining. 
Flash chromatography was carried out using silica gel, with the eluent specified.  
Infrared spectra were recorded using an FT-IR spectrometer over the range 4000-600 cm-1. 
NMR spectra were recorded at 400 or 500 MHz (1H frequency, 100 or 125 MHz 13C 
frequency). Chemical shifts are quoted in parts per million (ppm), and are referenced to 
residual H in the deuterated solvent as the internal standard. Coupling constants, J, are quoted 
in Hz. In the 13C NMR spectra, signals corresponding to CH, CH2, or CH3 groups are 
assigned from DEPT. Mass spectra were recorded on a time-of-flight mass spectrometer using 
electrospray ionization (ESI), or an EI magnetic sector instrument.  
 
3.2 3,5-Dibenzyloxy-2-trimethylsilylphenyl trifluoromethanesulfonate 5 
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The title compound was prepared by the method of Stoltz and co-workers.24 
 
3.3 Methyl 4-benzyloxy-2-hydroxybenzoate 7 
OH
CO2Me
BnO  
A mixture of methyl 2,4-dihydroxybenzoate 6 (4.00 g, 23.8 mmol) and anhydrous potassium 
carbonate (4.90 g, 35.7 mmol) in acetone (22 mL) was stirred at room temperature for 5 min. 
Benzyl bromide (2.83 mL, 23.8 mmol) was added dropwise and the mixture was stirred at 10-
15 °C for 3 h. Water (30 mL) and ethyl acetate (30 mL) were added and the two phases were 
separated. The aqueous phase was extracted with further ethyl acetate (3 × 40 mL). The 
combined organic layers were washed with brine (40 mL), dried over MgSO4, filtered and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography (9 : 1 light petroleum-ethyl acetate) to give the title compound (5.06 g, 82%) 
as a colorless solid, mp 103-105 °C (lit.,29 mp 103-105 °C); (Found: [M+Na+], 281.0781. 
C15H14NaO4+ requires 281.0784); vmax (CHCl3)/cm-1 3008, 2956, 1668, 1623, 1583, 1505, 
1441, 1382, 1349, 1255, 1183, 1142, 1099, 1014; δH (400 MHz; DMSO-d6) 10.78 (1 H, s); 
7.74 (1 H, d, J 7.2), 7.47 – 7.36 (5 H, m), 6.64 – 6.61 (2 H, m), 5.18 (2 H, s), 3.88 (3 H, s); δC 
(100 MHz; DMSO-d6) 169.8 (C), 164.7 (C), 163.0 (C), 136.8 (C), 131.8 (CH), 128.9 (CH), 
128.5 (CH), 128.2 (CH), 108.5 (CH), 105.9 (C), 102.4 (CH), 70.1 (CH2), 52.7 (Me).  
 
3.4 Methyl 4-benzyloxy-2,5-dihydroxybenzoate 8 
OH
CO2MeHO
BnO  
To a stirred mixture of methyl 4-benzyloxy-2-hydroxybenzoate 7 (3.50 g, 13.5 mmol) in 
aqueous solution of NaOH (1 M; 135 mL) at 0 °C, was added over 30 min, a solution of 
potassium persulfate (7.70 g, 28.5 mmol) in water (135 mL). After stirring for 20 h at room 
temperature, the reaction mixture was acidified to pH 4 with concentrated hydrochloric acid. 
The mixture was filtered to remove the unreacted starting material (2.25 g, 64% recovery). 
Further concentrated hydrochloric acid (30 mL) was added to the aqueous phase and the 
mixture heated to 80 °C for 2 h. After cooling to room temperature, ethyl acetate (150 mL) 
was added, and then the aqueous layer was extracted with further ethyl acetate (3 × 200 mL). 
The combined organic phases were dried over MgSO4 and evaporated to give a dark oil that 
was purified by column chromatography (9 : 1 light petroleum-ethyl acetate). The product 
was crystallized from methanol to give the title compound as a colorless solid (560 mg, 15%), 
mp 165-167 °C; (Found: [M+Na+], 297.0716. C15H14NaO5+ requires 297.0733); vmax 
(CHCl3)/cm-1 3684, 3555, 3011, 2956, 1669, 1635, 1509, 1440, 1399, 1374, 1276, 1239, 
1168, 1082, 1000; δH (400 MHz; DMSO-d6) 10.33 (1 H, s), 8.94 (1 H, s), 7.50 – 7.35 (5 H, 
m), 7.18 (1 H, s), 6.63 (1 H, s), 5.18 (2 H, s), 3.86 (3 H, s); δC (100 MHz; DMSO-d6) 170.0 
(C), 156.1 (C), 154.2 (C), 140.1 (C), 136.9 (C), 128.9 (CH), 128.4 (CH), 128.2 (CH), 114.4 
(CH), 103.7 (C), 102.1 (CH), 70.2 (CH2), 52.6 (Me),  
 
3.5 Methyl 4-benzyloxy-2-hydroxy-5-methoxymethoxybenzoate 4 
OH
CO2MeMOMO
BnO  
To a solution of methyl 4-benzyloxy-2,5-dihydroxybenzoate 8 (450 mg, 1.64 mmol) in 
dichloromethane (18 mL) at 0 °C, were added DIPEA (0.51 mL, 2.95 mmol), and after few 
minutes, MOMCl (0.14 mL, 1.8 mmol). The mixture was stirred for 2 h at room temperature. 
Water (15 mL) was added and the mixture was extracted with ethyl acetate (3 × 15 mL). The 
combined organic extract was dried over MgSO4, and evaporated. The residue was purified 
by flash column chromatography (9:1 light petroleum-ethyl acetate) to give the title 
compound as a colorless solid (410 mg, 70%), mp 103-105 °C, (Found: [M+Na+], 341.0994. 
C17H18NaO6+ requires 341.0996); vmax (CHCl3)/cm-1 3154, 3011, 2955, 1668, 1620, 1511, 
1497, 1441, 1355, 1259, 1192, 1162, 1097, 1070, 988; δH (400 MHz; DMSO-d6) 10.58 (1 H, 
s), 7.48 – 7.37 (6 H, m), 6.73 (1 H, s), 5.20 (2 H, s), 5.09 (2 H, s), 3.88 (3 H, s), 3.39 (3 H, s); 
δC (100 MHz; DMSO-d6) 169.7 (C), 158.4 (C), 156.3 (C), 139.5 (C), 136.6 (C), 129.0 (CH), 
128.6 (CH), 128.3 (CH), 117.8 (CH), 103.9 (C), 102.4 (CH), 96.2 (CH2), 70.5 (CH2), 56.2 
(Me), 52.7 (Me).  
 
3.6 1,3,6-Tribenzyloxy-7-methoxymethoxy-9H-xanthen-9-one 9 
O
O
MOMO
BnO
OBn
OBn  
To a solution of methyl 4-benzyloxy-2-hydroxy-5-methoxymethoxybenzoate 4 (409 mg, 1.28 
mmol) in THF (15 mL), was added sodium hydride ([60% dispersion in mineral oil] 52 mg, 
1.29 mmol) and the mixture was left to stir for 45 min. The mixture was heated to 65 °C and 
cesium fluoride (780 mg, 5.14 mmol) was added, followed by a solution of 3,5-dibenzyloxy-
2-trimethylsilylphenyl trifluoromethanesulfonate 5 (720 mg, 1.41 mmol) in THF (10 mL), 
over 30 min. The mixture was stirred for 24 h at 65 °C, then cooled, and diluted with ether 
(100 mL), and washed with brine (100 mL). The aqueous layer was extracted with ethyl 
acetate (2 × 60 mL), the combined organic extracts dried over MgSO4, filtered and 
evaporated. The residue was purified by flash column chromatography (8:2 light petroleum-
ethyl acetate) to give the title compound as a light brown solid (295 mg, 40%), mp 148-150 
°C; (Found: [M+H+], 575.2062. C36H31O7+ requires 575.2064); vmax (CHCl3)/cm-1 3068, 3010, 
2931, 1715, 1644, 1624, 1606, 1499, 1453, 1438, 1376, 1268, 1182, 1156, 1122, 1076; δH 
(400 MHz; CDCl3) 8.00 (1 H, s,), 7.67 (2 H, d, J 7.1), 7.51 – 7.34 (13 H, m), 6.87 (1 H, s, H-
5), 6.55 (1 H, d, J 2.3), 6.50 (1 H, d, J 2.3), 5.31 (2 H, s), 5.27 (2 H, s), 5.25 (2 H, s), 5.14 (2 
H, s), 3.56 (3 H, s); δC (100 MHz; CDCl3) 174.3 (C), 163.3 (C), 160.7 (C), 159.7 (C), 154.6 
(C), 151.6 (C), 143.9 (C), 136.4 (C), 135.9 (C), 135.8 (C), 128.8 (CH × 2), 128.6 (CH), 128.4 
(CH), 128.3 (CH), 127.7 (CH), 127.6 (CH), 127.2 (CH), 126.8 (CH), 116.6 (C), 113.2 (CH), 
107.5 (C), 101.0 (CH), 97.2 (CH), 96.1 (CH2), 94.0 (CH), 71.0 (CH2), 70.8 (CH2), 70.5 
(CH2), 56.4 (Me). 
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Also formed was methyl 4-benzyloxy-2-(3,5-dibenzyloxy)phenoxy-5-methoxymethoxybenzoate 
10 (235 mg, 30%), mp 70-71 °C, (Found: [M+Na+], 629.2125. C37H34NaO8+ requires 
629.2146); vmax (CHCl3)/cm-1 3091, 3068, 3009, 1715, 1605, 1509, 1455, 1265, 1155, 1129; 
δH (400 MHz; CDCl3) 7.73 (1 H, s), 7.44 – 7.28 (15 H, m), 6.60 (1 H, s), 6.35 (1 H, t, J 2.1), 
6.12 (2 H, d, J 2.1), 5.24 (2 H, s), 5.05 (2 H, s), 4.97 (4 H, s), 3.75 (3 H, s), 2.90 (3 H, s); δC 
(100 MHz; CDCl3) 165.0 (C), 160.7 (C), 160.3 (C), 153.6 (C), 151.5 (C), 143.1 (C), 136.7 
(C), 135.8 (C), 128.7 (CH), 128.6 (CH), 128.2 (CH), 128.1 (CH), 127.6 (CH), 127.4 (CH), 
120.1 (CH), 115.3 (C), 108.0 (CH), 96.9 (CH), 96.5 (CH), 96.1 (CH2), 70.7 (CH2), 70.1 
(CH2), 56.5 (Me), 52.0 (Me). 
 
3.7 1,3,6-Tribenzyloxy-7-methoxymethoxy-9H-xanthen-9-one 9 (method 2) 
To a solution of methyl 4-benzyloxy-2-(3,5-dibenzyloxy)phenoxy-5-
methoxymethoxybenzoate 10 (500 mg, 0.83 mmol) in methanol (14 mL) at 0 °C, was added a 
solution of LiOH (395 mg, 16.5 mmol) in a mixture of THF/water (1:1, 7 mL), and the 
mixture was stirred at room temperature for 7 h. The mixture was concentrated under reduced 
pressure, the residue diluted with water (5 mL) and acidified to pH 6 with hydrochloric acid 
(2 M), and then extracted with ethyl acetate (3 × 20 mL). The combined organic extract was 
dried with MgSO4 and concentrated under reduced pressure, to give the benzoic acid that was 
used immediately in the next step. 
The above acid was taken up in dichloromethane (9 mL) and the solution cooled to 0 °C. 
Trifluoroacetic anhydride (0.69 mL, 4.95 mmol) was added slowly and the mixture was 
stirred for 3 h at room temperature. After this period, the mixture was concentrated under 
reduced pressure and diluted with a saturated solution of sodium hydrogen carbonate (10 
mL). The mixture was extracted with dichloromethane (3 × 15 mL) and the combined organic 
fraction was dried over MgSO4 and concentrated under reduced pressure to give the title 
compound as a solid (465 mg, 99%) that did not require further purification.  
 
3.8 7-Hydroxy-1,3,6-tribenzyloxy-9H-xanthen-9-one 11 
O
O
HO
BnO
OBn
OBn  
To a solution of 1,3,6-tribenzyloxy-7-methoxymethoxy-9H-xanthen-9-one 9 (380 mg, 0.66 
mmol) in anhydrous dichloromethane (24 mL) at 0 °C, was added trifluoroacetic acid (4 mL), 
and the reaction mixture was stirred for 30 min at room temperature. Saturated sodium 
hydrogen carbonate (30 mL) was added slowly and the mixture extracted with ethyl acetate (3 
× 30 mL). The combined organic extracts were washed with saturated brine (10 mL), dried 
over MgSO4, filtered and concentrated under reduced pressure. The residual oil was purified 
by flash column chromatography (7:3 light petroleum-ethyl acetate) to give the title 
compound as colorless solid (330 mg, 94%), mp 173-175 °C, (Found: [M+H+], 531.1814. 
C34H27O6+ requires 531.1802); vmax (CHCl3)/cm-1 3687, 3603, 3011, 1630, 1602, 1500, 1438, 
1272, 1239, 1174, 1118, 1017; δH (400 MHz; CDCl3) 7.82 (1 H, s), 7.62 (2 H, d, J 7.3), 7.48 – 
7.35 (13 H, m), 6.91 (1 H, s), 6.54 (1 H, s), 6.48 (1 H, s), 5.27 (2 H, s), 5.24 (2 H, s), 5.13 (2 
H, s); δC (100 MHz; CDCl3) 175.0 (C), 163.5 (C), 160.7 (C), 159.8 (C), 151.2 (C), 150.2 (C), 
143.0 (C), 136.3 (C), 135.7 (C), 135.0 (C), 129.0 (CH), 128.9 (CH), 128.8 (CH), 128.7 (CH), 
128.4 (CH), 127.9 (CH), 127.8 (CH), 127.6 (CH), 126.8 (CH), 117.0 (C), 109.9 (CH), 107.3 
(C), 99.6 (CH), 97.1 (CH), 94.0 (CH), 71.6 (CH2), 70.8 (CH2), 70.5 (CH2).  
 
3.9 3,6-Dibenzyloxy-1,7-dihydroxy-9H-xanthen-9-one 12 
O
O
HO
BnO
OH
OBn  
Anhydrous magnesium bromide (118 mg, 0.641 mmol) was added to 7-hydroxy-1,3,6-
tribenzyloxy-9H-xanthen-9-one 11 (68 mg, 0.128 mmol) in toluene (2 mL) and the yellow 
suspension was heated to reflux and stirred for 15 h, turning deep red. Hydrochloric acid (5 
mL) was added, and the aqueous phase was extracted with ethyl acetate (3 × 10 mL). The 
combined organic extracts were washed with water (30 mL) and brine (30 mL), dried 
(MgSO4) and concentrated. The residue was purified by flash column chromatography (2:3 
ethyl acetate – light petroleum) to give the title compound as a pale yellow solid (5 mg, 10%); 
mp 173-174 °C, (Found: [M+Na+], 463.1149. C27H20NaO6+ requires 463.1200); vmax 
(CHCl3)/cm-1 3632, 3550, 3071, 3013, 2947, 2890, 2852, 1654, 1614, 1488, 1289, 1174; δH 
(400 MHz; DMSO-d6) 13.07 (1 H, s), 9.87 (1 H, s), 7.53 – 7.56 (10 H, m), 7.23 – 7.21 (2 H, 
m), 6.65 (1 H, d, J 2.2), 6.46 (1 H, d, J 2.2), 5.31 (2 H, s), 5.25 (2 H, s); δC (100 MHz; 
DMSO-d6) 179.6 (C), 165.2 (C), 162.8 (C), 157.6 (C), 154.7 (C), 151.2 (C), 145.2 (C), 136.6 
(C), 129.0 (CH), 128.8 (CH), 128.7 (CH), 128.6 (CH), 128.43 (CH), 128.40 (CH), 113.3 (C), 
108.2 (CH), 103.2 (C), 101.8 (CH), 97.9 (CH), 93.7 (CH), 70.8 (CH2), 70.5 (CH2). 
 
3.10 7-(2,2-Dimethylbut-3-ynyl)-1,3,6-tribenzyloxy-9H-xanthen-9-one 13 
O
O
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Potassium carbonate (82 mg, 0.594 mmol) and potassium iodide (82 mg, 0.49 mmol) were 
added to a solution of 7-hydroxy-1,3,6-tribenzyloxy-9H-xanthen-9-one 11 (150 mg, 0.283 
mmol) in acetone (15 mL). 3-Chloro-3-methyl-1-butyne (80 µL, 0.707 mmol) was added in a 
single portion and the reaction mixture was heated to reflux and stirred for 48 h. After 
cooling, ether (60 mL) was added, and the ethereal solution was washed with aqueous NaOH 
(1 M; 3 × 10 mL). The organic layer was dried over MgSO4 and concentrated under reduced 
pressure to give a solid. This was purified by flash column chromatography (8:2 light 
petroleum-ethyl acetate) to give the title compound as a colorless solid (125 mg, 75%), mp 
161-163 °C, (Found: [M+H+], 597.2287. C39H33O6+ requires 597.2272); vmax (CHCl3)/cm-1 
3305, 3011, 1645, 1623, 1605, 1498, 1443, 1379, 1270, 1182, 1119, 1048, 1028; δH (400 
MHz; CDCl3) 8.28 (1 H, s), 7.65 (2 H, d, J 7.3), 7.52 (2 H, d, J 7.3), 7.46 – 7.34 (11 H, m), 
6.89 (1 H, s), 6.55 (1 H, d, J 1.8), 6.49 (1 H, d, J 1.8), 5.28 (2 H, s), 5.20 (2 H, s), 5.13 (2 H, 
s), 2.57 (1 H, s), 1.72 (6 H, s); δC (100 MHz; CDCl3) 174.5 (C), 163.2 (C), 160.7 (C), 159.7 
(C), 157.4 (C), 152.5 (C), 142.2 (C), 136.4 (C), 136.9 (C), 135.7 (C), 128.8 (CH), 128.7 (CH), 
128.6 (CH), 128.4 (CH), 128.1 (CH), 127.7 (CH), 127.6 (CH), 127.2 (CH), 126.8 (CH), 119.9 
(CH), 116.4 (C), 107.6 (C), 100.7 (CH), 97.2 (CH), 94.1 (CH), 85.5 (C), 74.9 (C), 74.3 (CH), 
70.9 (CH2), 70.8 (CH2), 70.5 (CH2), 29.6 (Me). 
 
3.11 5,9,11-Tribenzyloxy-3,3-dimethylpyrano[3,2-a]xanthen-12(3H)-one 14 
O
O
O
BnO
OBn
OBn
Me
Me
 
A solution of 7-(2,2-dimethylbut-3-ynyl)-1,3,6-tribenzyloxy-9H-xanthen-9-one 13 (10 mg, 
0.02 mmol) in toluene (2 mL) was heated under reflux for 2.5 h. The solvent was evaporated 
and the residue purified by flash column chromatography (4:1 light petroleum-ethyl acetate) 
to give the title compound as a colorless solid (10 mg, 100%), mp 174-175 °C; (Found: 
[M+H+], 597.2283. C39H33O6+ requires 597.2272); vmax (CHCl3)/cm-1 3011, 2928, 1701, 1615, 
1438, 1378, 1274, 1192, 1166, 1125, 1059, 1016; δH (400 MHz; CDCl3) 8.14 (1 H, d, J 9.8), 
7.62 (2 H, d, J 7.3), 7.49 – 7.35 (13 H, m), 6.74 (1 H, s), 6.48 (1 H, d, J 2.1), 6.43 (1 H, d, J 
2.1), 5.85 (1 H, d, J 9.8), 5.30 (4 H, s), 5.09 (2 H, s), 1.53 (6 H, s); δC (100 MHz; CDCl3) 
176.9 (C), 162.9 (C), 160.5 (C), 158.8 (C), 152.3 (C), 151.3 (C), 139.8 (C), 136.6 (C), 136.4 
(C), 135.8 (C), 131.8 (CH), 128.8 (CH × 2), 128.7, 128.6, 128.4 (CH), 128.0 (CH), 127.6 (CH 
× 2), 126.9, 126.7 (CH × 2), 121.6 (CH), 120.9 (C), 111.8 (C), 108.5 (C), 101.1 (CH), 97.3 
(CH), 93.5 (CH), 75.3 (C), 70.8 (CH2), 70.7 (CH2), 70.4 (CH2), 27.1 (Me).  
 
3.12 5,9,11-Trihydroxy-3,3-dimethylpyrano[3,2-a]xanthen-12(3H)-one (toxyloxanthone 
B) 3a 
 
To a stirred solution of 5,9,11-tribenzyloxy-3,3-dimethylpyrano[3,2-a]xanthen-12(3H)-one 14 
(2 mg, 0.005 mmol), and pentamethylbenzene (7 mg, 0.048 mmol) in dry dichloromethane (1 
mL) at -78 °C, was added BCl3 (solution 1.0 M in dichloromethane; 0.03 mL) dropwise over 
10 min. After 30 min at -78 °C, the reaction mixture was warmed to room temperature and 
stirred for 16 h. TLC and MS analysis showed the presence of the mono-benzylated 
compound, so extra BCl3 (solution 1.0 M in dichloromethane; 0.03 mL) was added and the 
reaction mixture was stirred for a further 1 h, before being quenched with a mixture of 
chloroform and methanol (9:1, 2 mL). The excess solvent was removed under reduced 
pressure. The residue was purified by flash chromatography (4:1 light petroleum-ethyl 
acetate) to give the title compound as a pale yellow solid (1 mg, 64%), mp 318-319 °C (lit.,17 
mp 304-306 °C); (Found: [M+H+], 327.0864. C18H15O6+ requires 327.0863); vmax (CHCl3)/cm-
1 3691, 3607, 1701, 1602, 1456, 1249, 1028, 850; δH (500 MHz; acetone-D6) 13.38 (1 H, s, 
11-OH), 9.60 (1 H, br. s, 5-OH), 9.18 (1 H, br. s, 9-OH), 8.03 (1 H, d, J 10.2, H-1), 6.82 (1 H, 
s, H-6), 6.34 (1 H, d, J 2.1, H-8), 6.21 (1 H, d, J 2.1, H-10), 5.94 (1 H, d, J 10.2, H-2), 1.46 (6 
H, s, Me-13); δC (125 MHz; acetone-D6) 180.5 (C=O), 165.3 (C-7a), 163.3 (C-11), 157.0 (C-
9), 157.0 (C-6a), 155.6 (C-5), 141.3 (C-4a) 129.6 (CH-2), 122.2 (CH-1), 118.0 (C-12b), 103.2 
(CH-6), 102.0 (C-11a), 101.6 (C-12a), 97.6 (CH-10), 93.0 (CH-8), 74.9 (C-3), 26.2 (Me-13). 
 
3.13 5,9,11-Trimethoxy-3,3-dimethylpyrano[3,2-a]xanthen-12(3H)-one (toxyloxanthone 
B trimethyl ether) 3b 
 
To a stirred solution of 5,9,11-trihydroxy-3,3-dimethylpyrano[3,2-a]xanthen-12(3H)-one 3a 
(2 mg, 0.006 mmol), and anhydrous potassium carbonate (5 mg, 0.037 mmol) in acetone (1 
mL), was added dimethyl sulfate (0.002 mL) and the mixture was heated to reflux and stirred 
for 16 h. The excess of solvents was removed under reduced pressure and the residue was 
purified by flash chromatography (4:1 light petroleum-ethyl acetate to 2:1 light petroleum-
ethyl acetate) to give the title compound as a colorless solid (2 mg, 89%), mp 125-126 °C 
(lit.,16 mp 192-193 °C); (Found: [M+H+], 369.1343. C21H21O6+ requires 369.1333); vmax 
(CHCl3)/cm-1 3156, 2903, 2254, 1795, 1618, 1467, 1383, 1097, 905, 650; δH (500 MHz; 
(CD3)2CO) 8.10 (1 H, d, J 10.2, H-1), 6.73 (1 H, s, H-6), 6.42 (1 H, d, J 2.3, H-8), 6.32 (1 H, 
d, J 2.3, H-10), 5.77 (1 H, d, J 10.2, H-2), 3.97 (3 H, s, 11-OMe), 3.95 (3 H, s, 5-OMe), 3.90 
(3 H, s, 9-OMe), 1.48 (6 H, s, 3-Me); δC (125 MHz; (CD3)2CO) 177.2 (C), 164.1 (C), 161.8 
(C), 158.9 (C), 153.4 (C), 151.6 (C), 139.2 (C), 131.6 (CH), 121.5 (CH), 120.7 (C), 111.2 
(CH), 107.9 (C), 98.7 (C), 95.0 (CH), 92.1 (CH), 75.4 (C), 56.3 (OMe), 56.2 (OMe), 55.6 
(OMe), 27.1 (Me). 
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